FertilityBlend(R) Significantly Improves Pregnancy Rate According to Breakthrough Study Published in Clinical and Experimental Obstetrics and Gynecology
A pioneering clinical study on the role of nutritional supplementation in reproductive health is published in the Winter issue of the peer-reviewed journal, Clinical and Experimental Obstetrics and Gynecology (Volume 33, Issue 4). The double-blind, placebo-controlled study offers dramatic results and provides an appealing alternative for women attempting to conceive. These results corroborate the earlier pilot study findings, published in the April 2004 issue of Journal of Reproductive Medicine (Volume 49, Issue 4).
Conducted with investigators at the Stanford University School of Medicine, the study found a statistically significant increase in pregnancy rate, following nutritional supplementation with FertilityBlend® for six months, as well as improvement in women’s mid-luteal phase progesterone levels, and basal body temperatures according to the co-authors, Lynn Westphal, M.D., Assistant Professor and Division Chief, Department of Reproductive Endocrinology and Infertility, and Mary Lake Polan, M.D., Ph.D., M.P.H., Professor and Chair Emeritus, Department of Gynecology and Obstetrics Stanford University School of Medicine.
After six months, 17 of the 53 women in the FB group were pregnant (32%), while only four of the 40 women in the placebo group were pregnant (10%). This difference is statistically significant at p=0.01. No negative side effects were noted. “We were very pleased when these expanded study results held up to the original pilot study findings,” said Lynn Westphal, MD. “There’s not a lot of work in this area but it’s an important one,” she said. “Many women are interested in avenues aside from aggressive infertility treatment. If we can find an effective way to treat patients less invasively, it would be a great benefit.”
Infertility is a major problem in the US and worldwide. One out of every six couples in the U.S., and one out of every three couples in their late 30′s, has difficulty conceiving a child. An ever-increasing number of couples are leaning towards trying natural remedies first, which may help change the paradigm of how infertility is evaluated and treated.
“It surprised us when this nutritional supplement worked as well as it did,” says Dr. Lynn Westphal. “Nutritional supplementation may play an important role in optimizing fertility health, leading to improved conception rates, and could provide an effective alternative or adjunct to conventional fertility therapies, particularly in cases of menstrual irregularity or unexplained infertility.”
“Good nutrition is a pre-requisite for fertility and childbearing, and is particularly important for those deciding to become pregnant at a more advanced age,” says Professor and Chair Emeritus of Gynecology and Obstetrics at Stanford, Dr. Mary Lake Polan. “This expanded study data is persuasive and provides an important option for women.”
The study conducted on FertilityBlend® is the first of its kind for a nutritional supplement in the reproductive health category. Ninety-three (93) women, age 24-42 years, who had tried unsuccessfully to conceive for 6-36 months, completed the study. Women who took FertilityBlend became pregnant at over three times the rate of those who did not take it. In addition to the dramatic increase in pregnancy in the FertilityBlend® group, improvement was also noted in the women’s mid-luteal phase progesterone levels, basal body temperatures, and cycle length, as major indicators of the body’s readiness to conceive.
So far, in a similar 3 month study of FertilityBlend® for Men, sperm counts have increased by an average of 62 percent, sperm motility increased by 33 percent, and sperm linearity was also significantly enhanced in the treatment group. The placebo group did not show any significant changes.
FertilityBlend® for Women ingredients include chasteberry (vitex agnus-castus) — an herb that encourages healthy ovulation; folic acid — for the prevention of certain birth defects; green tea, vitamin E and selenium — antioxidants that may promote reproductive wellness; L-arginine — an essential amino acid that benefits sexual and reproductive health; plus vitamins B6 and B12, iron, magnesium and zinc – nutrients which can be directly related to fertility health.
FertilityBlend® for Men improves sperm health. Ingredients include L-carnitine — an amino acid critical to the formation of healthy, active sperm; ferulic acid — an antioxidant shown to improve sperm quality; vitamins C and E, green tea and selenium-antioxidants essential for overall reproductive health; plus zinc, folic acid and vitamins B6 and B12 — nutrients involved in hormone metabolism, sperm formation and motility.
The United States Patent and Trademark Office has granted patent 6,497,885, and 6,989,164 to the Daily Wellness Company for FertilityBlend® covering both “Method and Composition for Improving Fertility Health in Female and Male Animals and Humans”. FertilityBlend® is available nationwide in leading drug stores including Eckerd, Rite Aid, GNC and health food stores, and is sold overseas in: South Africa, Namibia, Botswana, Mozambique, Zimbabwe, Swaziland, and Nigeria, The United Kingdom, The Netherlands, Spain, The Republic of Korea, Singapore, and Australia. FertilityBlend® is available on line at www.fertilityblend.com, or by calling 1-866-Baby-To-B.
Interviews with medical experts and FertilityBlend® study participants are available. The REI lab at Stanford Hospital performed the progesterone and sperm analysis and the study was funded by a non-profit organization, The David Sen Lin Foundation.